- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Normative influence.
Displaying page 1 of 1.
| EudraCT Number: 2016-002635-15 | Sponsor Protocol Number: 15-06 | Start Date*: 2016-07-28 |
| Sponsor Name:VU Medical Center | ||
| Full Title: Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age | ||
| Medical condition: The protective factors of Alzheimer's disease in subjects aged 90 years and older | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-003991-37 | Sponsor Protocol Number: AGO/2006/009 | Start Date*: 2006-12-13 | |||||||||||
| Sponsor Name:University Hospital Gent | |||||||||||||
| Full Title: Trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome | |||||||||||||
| Medical condition: Marfan syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-002745-38 | Sponsor Protocol Number: GEIS-30 | Start Date*: 2012-10-22 | ||||||||||||||||
| Sponsor Name:Grupo Español de Investigación en Sarcomas | ||||||||||||||||||
| Full Title: Phase II Clinical Trial of Pazopanib to evaluate the activity and tolerability in patients with advanced and/or metastatic liposarcoma who have relapsed following standard therapies or for whom no ... | ||||||||||||||||||
| Medical condition: Advanced and/or metastatic liposarcoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Completed) DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2008-008922-55 | Sponsor Protocol Number: GEIS20 | Start Date*: 2009-06-04 | |||||||||||
| Sponsor Name:Grupo Español de Investigación en Sarcomas | |||||||||||||
| Full Title: ENSAYO FASE II ALEATORIZADO, ABIERTO, MULTICÉNTRICO Y PROSPECTIVO DE DOXORRUBICINA vs TRABECTEDINA Y DOXORRUBICINA EN PRIMERA LÍNEA DE PACIENTES CON SARCOMA DE PARTES BLANDAS AVANZADOS NO OPERABLES... | |||||||||||||
| Medical condition: Sarcoma de partes blandas avanzados no operables y/o metastásicos | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.